Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses

INTRODUCTION: Janus kinases (JAK) inhibitors demonstrated to be effective in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis (RA) but have been associated with serious cardiovascular and serious events. Two systematic reviews and network meta-analyses will be carr...

Celý popis

Podrobná bibliografie
Hlavní autoři: Alves, Carlos, Penedones, Ana, Mendes, Diogo, Batel-Marques, Francisco
Médium: Online Článek Text
Jazyk:English
Vydáno: BMJ Publishing Group 2020
Témata:
Rheumatology
On-line přístup:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/
https://www.ncbi.nlm.nih.gov/pubmed/33384392
http://dx.doi.org/10.1136/bmjopen-2020-041420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/
https://www.ncbi.nlm.nih.gov/pubmed/33384392
http://dx.doi.org/10.1136/bmjopen-2020-041420

Podobné jednotky